Risk Factors and Outcomes of Very Young Adults Who Experience Myocardial Infarction: The Partners YOUNG-MI Registry.
Premature coronary artery disease
Risk factors
Very young adults
Journal
The American journal of medicine
ISSN: 1555-7162
Titre abrégé: Am J Med
Pays: United States
ID NLM: 0267200
Informations de publication
Date de publication:
05 2020
05 2020
Historique:
received:
09
09
2019
revised:
20
10
2019
accepted:
21
10
2019
pubmed:
13
11
2019
medline:
24
6
2020
entrez:
13
11
2019
Statut:
ppublish
Résumé
Despite significant progress in primary prevention, the rate of myocardial infarction has not decreased in young adults. We sought to compare the risk factor profiles and outcomes between individuals who experienced a first myocardial infarction at a very young (≤40 years) and a young (age 41-50 years) age. We evaluated all patients ≤50 years of age admitted with a Type 1 myocardial infarction to 2 large academic hospitals from 2000 to 2016. Risk factors were determined by review of electronic medical records. The primary outcomes of interest were all-cause and cardiovascular mortality. Among 2097 consecutive young patients with myocardial infarction, 431 (20.5%) were ≤40 years of age. When compared with their older counterparts, very young patients had similar risk profiles, with the exception of greater substance abuse (17.9% vs 9.3%, P < .001) and less hypertension (37.9% vs 50.9%, P < .001). Spontaneous coronary artery dissection was more prevalent in very young patients (3.1% vs 1.1%, P = .003). Over a median follow-up of 11.2 years, very young myocardial infarction patients had a similar risk of all-cause and cardiovascular mortality. Despite being, on average, 10 years younger and having a lower prevalence of hypertension, very young myocardial infarction patients had similar 1-year and long-term outcomes when compared with those aged 41 to 50 years at the time of their index infarction. Our findings suggest the need for aggressive secondary prevention measures in very young patients who experience a myocardial infarction.
Sections du résumé
BACKGROUND
Despite significant progress in primary prevention, the rate of myocardial infarction has not decreased in young adults. We sought to compare the risk factor profiles and outcomes between individuals who experienced a first myocardial infarction at a very young (≤40 years) and a young (age 41-50 years) age.
METHODS
We evaluated all patients ≤50 years of age admitted with a Type 1 myocardial infarction to 2 large academic hospitals from 2000 to 2016. Risk factors were determined by review of electronic medical records. The primary outcomes of interest were all-cause and cardiovascular mortality.
RESULTS
Among 2097 consecutive young patients with myocardial infarction, 431 (20.5%) were ≤40 years of age. When compared with their older counterparts, very young patients had similar risk profiles, with the exception of greater substance abuse (17.9% vs 9.3%, P < .001) and less hypertension (37.9% vs 50.9%, P < .001). Spontaneous coronary artery dissection was more prevalent in very young patients (3.1% vs 1.1%, P = .003). Over a median follow-up of 11.2 years, very young myocardial infarction patients had a similar risk of all-cause and cardiovascular mortality.
CONCLUSIONS
Despite being, on average, 10 years younger and having a lower prevalence of hypertension, very young myocardial infarction patients had similar 1-year and long-term outcomes when compared with those aged 41 to 50 years at the time of their index infarction. Our findings suggest the need for aggressive secondary prevention measures in very young patients who experience a myocardial infarction.
Identifiants
pubmed: 31715169
pii: S0002-9343(19)30962-3
doi: 10.1016/j.amjmed.2019.10.020
pmc: PMC7210047
mid: NIHMS1555081
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
605-612.e1Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL142711
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL094301
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Références
Am J Med. 2014 Feb;127(2):140-4
pubmed: 24332726
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
Am J Med. 2012 Oct;125(10):1000-9
pubmed: 22748404
N Engl J Med. 2016 Dec 15;375(24):2349-2358
pubmed: 27959714
J Am Coll Cardiol. 2018 Jan 23;71(3):292-302
pubmed: 29141201
Heart Lung Circ. 2016 Oct;25(10):955-60
pubmed: 27265644
Int J Cardiol. 2008 May 7;126(1):127-9
pubmed: 17462762
Clin Cardiol. 2010 Mar;33(3):140-8
pubmed: 20235218
Int J Cardiol. 2011 May 5;148(3):300-4
pubmed: 19942306
Am J Cardiol. 2004 Oct 15;94(8):989-92
pubmed: 15476609
Circulation. 2017 May 30;135(22):2091-2101
pubmed: 28223407
Clin Res Cardiol. 2016 Nov;105(11):901-911
pubmed: 27364941
Clin Cardiol. 2017 Nov;40(11):955-961
pubmed: 28805969
J Am Coll Cardiol. 2015 Jul 28;66(4):403-69
pubmed: 25553722
Am Heart J. 2012 Apr;163(4):563-71
pubmed: 22520521
Eur Heart J. 2009 May;30(9):1073-9
pubmed: 19276196
J Am Coll Cardiol. 1995 Sep;26(3):654-61
pubmed: 7642855
Am J Cardiol. 1983 Feb;51(3):606
pubmed: 6823874
Diabetes Care. 2019 Sep 23;:
pubmed: 31548242
Ann Intern Med. 2018 Feb 6;168(3):187-194
pubmed: 29357394
J Am Coll Cardiol. 2014 Jul 29;64(4):337-45
pubmed: 25060366
Clin Cardiol. 1997 Dec;20(12):993-8
pubmed: 9422836
J Am Coll Cardiol. 2018 Jun 5;71(22):2540-2551
pubmed: 29535062
Arch Intern Med. 1997 Apr 28;157(8):865-9
pubmed: 9129546
Circulation. 2012 Jul 31;126(5):579-88
pubmed: 22800851
Circulation. 1993 Dec;88(6):2987-3007
pubmed: 8252713
Cardiology. 2007;107(4):217-25
pubmed: 16953107
J Am Coll Cardiol. 2012 Oct 16;60(16):1581-98
pubmed: 22958960
Am Heart J. 2002 Jan;143(1):56-62
pubmed: 11773912
Circulation. 2019 Aug 20;140(8):e331-e332
pubmed: 31424983
J Am Coll Cardiol. 2019 Feb 12;73(5):573-584
pubmed: 30732711